Gastric Cancer Marker Detection and Its Kit Development
Recruiting
Observational Study
Gastric Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Sex
Any
Study type
Observational
Participants needed
530 (estimated)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · Other
Who this trial is looking for
This trial is looking for adults with gastric cancer or healthy individuals to help develop a new diagnostic test. Participants will provide tissue samples to help find better ways to detect and treat gastric cancer.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 years old or older.
I have been diagnosed with gastric cancer.
I can provide tissue samples.
I have not received any anti-tumor treatment.
I agree to participate and sign the consent form.
You may not be able to join if
I do not have a specific type of tumor.
I have a history of other cancers or autoimmune diseases.
I have received anti-tumor treatments before.
I participated in another clinical trial in the last 90 days.
I had major surgery in the last 90 days.
I had a bone marrow transplant in the last 90 days.
I cannot complete the study for any reason.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The gastric cancer diagnosis and treatment specifications clearly point out that tumor markers need to be detected in the process of diagnosis, efficacy evaluation and follow-up. However, there is currently a lack of gastric cancer markers with high sensitivity and specificity, and the detection of markers is limited to a single index analysis, which has many shortcomings such as long analysis tim…
The gastric cancer diagnosis and treatment specifications clearly point out that tumor markers need to be detected in the process of diagnosis, efficacy evaluation and follow-up. However, there is currently a lack of gastric cancer markers with high sensitivity and specificity, and the detection of markers is limited to a single index analysis, which has many shortcomings such as long analysis time, large reagent consumption, and high detection cost. Therefore, this project will use protein chips to detect new types of gastric cancer patient markers and establish a multi-diagnostic model for early screening of gastric cancer. Finally, monoclonal antibodies will be produced against various high-specific tumor markers and a gastric cancer diagnostic kit will be established.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
patient
1. Age is greater than or equal to 18 years old (including 18 years old);
2. Patients who are diagnosed with cancer after pathological diagnosis;
3. Can provide enough tissue samples;
4. Have not received anti-tumor treatment in the past;
5. Comply with the principle of…
Inclusion Criteria:
patient
1. Age is greater than or equal to 18 years old (including 18 years old);
2. Patients who are diagnosed with cancer after pathological diagnosis;
3. Can provide enough tissue samples;
4. Have not received anti-tumor treatment in the past;
5. Comply with the principle of informed consent and sign the informed consent form.
healthy person:
1. Age is greater than or equal to 18 years old (including 18 years old);
2. No underlying disease;
3. Can provide enough tissue samples;
4. Comply with the principle of informed consent and sign the informed consent form.
Exclusion Criteria:
1. The tumor foci cannot be clearly derived from a specific tumor type;
2. Those who have a history of other tumors, autoimmune diseases and allergies;
3. Previously received anti-tumor treatments such as surgery, chemotherapy, radiotherapy, molecular targeted therapy, immunotherapy, biological therapy or Chinese medicines with anti-cancer and anti-tumor effects in the instructions;
4. Participated in any clinical trial within 90 days before the experiment;
5. Received major surgery within 90 days before the experiment;
6. Received bone marrow transplantation 90 days before the experiment;
7. Subjects who may not be able to complete the study due to other reasons or who are determined by the investigator to be unsuitable to participate in this study.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.